Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Shaomazhijing Granules for tic disorders in children
ChiCTR2300069340Phase 4Not yet recruiting
- Sponsor
- Data Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 4, open-label trial of Shaoma Zhijing granule in tic disorder (2 arms), sponsored by Data Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences. Primary endpoint: Yale Global Tic Severity Scale. Planned start May 2022; status: not yet recruiting.
02
Drugs
Shaoma Zhijing granule
03
Conditions
tic disorder
Beyond the preview
Go deeper on ChiCTR2300069340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069340.